Improving care of post-infarct patients: Effects of disease management programmes and care according to international guidelines

Clinical Research in Cardiology

Volumn 103, Issue 3, 2014, Pages 237-245

  Stark, Renee ^a   Kirchberger, Inge ^a   Hunger, Matthias ^a   Heier, Margit ^a   Leidl, Reiner ^a,b   Von Scheidt, Wolfgang ^c   Meisinger, Christa ^a   Holle, Rolf ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c KLINIKUM AUGSBURG   (Germany)

Author keywords

Coronary disease; Disease management; Secondary prevention

Indexed keywords

ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ARTICLE; CARDIAC DISEASE MANAGEMENT PROGRAM; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; DIET THERAPY; EXERCISE; FEMALE; HEALTH PROGRAM; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; PATIENT CARE; PRACTICE GUIDELINE; QUESTIONNAIRE; SECONDARY PREVENTION; SMOKING CESSATION; SURVIVAL;

AGED; CARDIOLOGY; FEMALE; GERMANY; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; QUALITY IMPROVEMENT; QUALITY INDICATORS, HEALTH CARE; QUESTIONNAIRES; REGISTRIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84897027585     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-013-0643-5     Document Type: Article

References (35)

1. Federal Ministry of Health Mortality statistics. Available from URL: www.gbe-bund.de/gbe10/F?F=14187D. Accessed on 01.08.2012
2. WHO (2012) Global atlas on cardiovascular disease prevention and control available on http://www.who.int/cardiovascular-diseases/publications/atlas-cvd/ en/index.html. Accessed 08.07.2013
3. Smith SC Jr, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, Grundy SM, Hiratzka L, Jones D, Krumholz HM, Mosca L, Pasternak RC, Pearson T, Pfeffer MA, Taubert KA (2006) AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 113(19):2363-2372. doi:10.1161/CIRCULATIONAHA.106.174516 (Pubitemid 43947981)
4. Federal Insurance Agency Basic facts of disease management programs in Germany, http://www.bundesversicherungsamt.de/cln-115/nn-1046154/DE/DMP/dmp- inhalt.html. Accessed 2 Aug 2012
5. Federal Joint Committee Directives regarding disease management programs in Germany, http://www.g-ba.de/downloads/62-492-353/2009-07-01-RSAV20.pdf (see page 1552 regarding CHD-DMP). Accessed November 6, 2012 2012
6. Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvanne M, Scholte op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F, European Association for Cardiovascular P, Rehabilitation, Guidelines ESCCfP (2012) European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth joint task force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 33(13):1635-1701. doi:10.1093/eurheartj/ehs092
7. Zeymer U, Junger C, Zahn R, Bauer T, Bestehorn K, Senges J, Gitt A (2011) Effects of a secondary prevention combination therapy with an aspirin, an ACE inhibitor and a statin on 1-year mortality of patients with acute myocardial infarction treated with a beta-blocker. Support for a polypill approach. Curr Med Res Opin 27(8):1563-1570. doi:10.1185/03007995.2011.590969
8. Federal Statistics Office Annual German Population on December 31st of each year, www.gbe-bund.de/gbe10/F?F=262D. Accessed 2 Aug 2012
9. Federal Statistics Office Prevalence of coronary heart disease diagnosed by a physician based on patient reports, www.gbe-bund.de/gbe10/F?F=204D Accessed 2 Aug 2012
10. Miksch A, Laux G, Ose D, Joos S, Campbell S, Riens B, Szecsenyi J (2010) Is there a survival benefit within a German primary care-based disease management program? Am J Manag Care 16(1):49-54. doi:12562
11. Drabik A, Buscher G, Thomas K, Graf C, Muller D, Stock S (2012) Patients with type 2 diabetes benefit from primary care-based disease management: a propensity score matched survival time analysis. Popul Health Manag 15(4):241-247. doi:10.1089/pop.2011.0063
12. Gapp O, Schweikert B, Meisinger C, Holle R (2008) Disease management programmes for patients with coronary heart disease - an empirical study of German programmes. Health Policy 88(2-3):176-185. doi:10.1016/j.healthpol.2008. 03.009
13. Holle R, Happich M, Lowel H, Wichmann HE, Group MKS (2005) KORA - a research platform for population based health research. Gesundheitswesen 67(Suppl 1):S19-S25. doi:10.1055/s-2005-858235
14. Kirchberger I, Heier M, Kuch B, Wende R, Meisinger C (2011) Sex differences in patient-reported symptoms associated with myocardial infarction (from the population-based MONICA/KORA Myocardial Infarction Registry). Am J Cardiol 107(11):1585-1589. doi:10.1016/j.amjcard.2011.01.040
15. Hostetter JC, Ghaffari S (2003) Should everyone with a recent myocardial infarction receive a beta-blocker and an ACE inhibitor? Clevel Clin J Med 70(1):46-48 (Pubitemid 36131385)
16. Leidl R, Reitmeir P (2011) A value set for the EQ-5D based on experienced health states: development and testing for the German population. Pharmacoeconomics 29(6):521-534. doi:10.2165/11538380-000000000-00000
17. Horton NJ, Lipsitz SR (2001) Multiple imputation in practice: comparison of software packages for regression models with missing variables. Am Stat 55(3):244-254 (Pubitemid 33318033)
18. Schunk M, Stark R, Reitmeir P, Rathmann W, Meisinger C, Holle R (2011) Improvements in type 2 diabetes care? Pooled analysis of survey data in southern Germany (KORA) from 1999-2008. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 54(11):1187-1196. doi:10.1007/s00103-011-1364-4
19. Stark RG, Schunk MV, Meisinger C, Rathmann W, Leidl R, Holle R, Grp KS (2011) Medical care of type 2 diabetes in German disease management programmes: a population-based evaluation. Diabetes Metab Res 27(4):383-391
20. Jolly K, Bradley F, Sharp S, Smith H, Thompson S, Kinmonth AL, Mant D (1999) Randomised controlled trial of follow up care in general practice of patients with myocardial infarction and angina: final results of the Southampton heart integrated care project (SHIP). The SHIP Collaborative Group. BMJ 318(7185):706-711 (Pubitemid 29191996)
21. Khunti K, Stone M, Paul S, Baines J, Gisborne L, Farooqi A, Luan X, Squire I (2007) Disease management programme for secondary prevention of coronary heart disease and heart failure in primary care: a cluster randomised controlled trial. Heart 93(11):1398-1405. doi:10.1136/hrt.2006.106955 (Pubitemid 351480139)
22. Law MR, Watt HC, Wald NJ (2002) The underlying risk of death after myocardial infarction in the absence of treatment. Arch Intern Med 162(21):2405-2410 (Pubitemid 35340454)
23. Kuch B, Heier M, von Scheidt W, Kling B, Hoermann A, Meisinger C (2008) 20-year trends in clinical characteristics, therapy and short-term prognosis in acute myocardial infarction according to presenting electrocardiogram: the MONICA/KORA AMI Registry (1985-2004). J Intern Med 264(3):254-264. doi:10.1111/j.1365-2796.2008.01956.x
24. McAlister FA, Lawson FM, Teo KK, Armstrong PW (2001) Randomised trials of secondary prevention programmes in coronary heart disease: systematic review. BMJ 323(7319):957-962 (Pubitemid 33016042)
25. Murphy AW, Cupples ME, Smith SM, Byrne M, Byrne MC, Newell J (2009) Effect of tailored practice and patient care plans on secondary prevention of heart disease in general practice: cluster randomised controlled trial. BMJ 339:b4220. doi:10.1136/bmj.b4220
26. Bailey TC, Noirot LA, Gage BF, Li X, Shannon WD, Waterman B, Sinha S, Bouselli DA, Reichley RM, Goldberg AC, Dunagan WC (2006) Improving adherence to coronary heart disease secondary prevention medication guidelines at a community hospital. AMIA Annual Symposium proceedings/AMIA Symposium AMIA Symposium:850
27. Tickoo S, Fonarow GC, Hernandez AF, Liang L, Cannon CP (2008) Weekend/holiday versus weekday hospital discharge and guideline adherence (from the American Heart Association's get with the guidelines - coronary artery disease database). Am J Cardiol 102(6):663-667. doi:10.1016/j.amjcard.2008.04. 053
28. Ctt C Cholesterol Treatment Trialists' (2012) The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet. doi:10.1016/S0140-6736(12)60367-5
29. Law MR, Morris JK, Wald NJ (2009) Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 338:b1665. doi:10.1136/bmj.b1665
30. Antithrombotic Trialists C, Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, Buring J, Hennekens C, Kearney P, Meade T, Patrono C, Roncaglioni MC, Zanchetti A (2009) Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 373(9678):1849-1860. doi:10.1016/S0140-6736(09)60503-1
31. Estruch R, Ros E, Salas-Salvado J, Covas MI, Corella D, Aros F, Gomez-Gracia E, Ruiz-Gutierrez V, Fiol M, Lapetra J, Lamuela-Raventos RM, Serra-Majem L, Pinto X, Basora J, Munoz MA, Sorli JV, Martinez JA, Martinez-Gonzalez MA, Investigators PS (2013) Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 368(14):1279-1290. doi:10.1056/NEJMoa1200303
32. Danaei G, Tavakkoli M, Hernan MA (2012) Bias in observational studies of prevalent users: lessons for comparative effectiveness research from a meta-analysis of statins. Am J Epidemiol 175(4):250-262. doi:10.1093/aje/kwr301
33. Joos S, Rosemann T, Heiderhoff M, Wensing M, Ludt S, Gensichen J, Kaufmann-Kolle P, Szecsenyi J (2005) ELSID-Diabetes study-evaluation of a large scale implementation of disease management programmes for patients with type 2 diabetes. Rationale, design and conduct - a study protocol [ISRCTN08471887]. BMC Public Health 5:99. doi:10.1186/1471-2458-5-99
34. Azaouagh A, Churzidse S, Konorza T, Erbel R (2011) Arrhythmogenic right ventricular cardiomyopathy/dysplasia: a review and update. Clinical Res Cardiol Off J Ger Cardiac Soc 100(5):383-394. doi:10.1007/s00392-011-0295-2
35. Dabiri Abkenari L, Theuns DA, Valk SD, Van Belle Y, de Groot NM, Haitsma D, Muskens-Heemskerk A, Szili-Torok T, Jordaens L (2011) Clinical experience with a novel subcutaneous implantable defibrillator system in a single center. Clin Res Cardiol Off J Ger Cardiac Soc 100(9):737-744. doi:10.1007/s00392-011- 0303-6